Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study

BACKGROUND: Colorectal cancer (CRC) is one of the most common cancers worldwide. Screening for CRC using the fecal occult blood test (FOBT) is feasible and useful for decreasing disease‐related mortality; however, its sensitivity and compliance are unsatisfactory. METHODS: This study examined the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Shu‐Chen, Tsao, Po‐Nien, Wang, Yu‐Ting, Lin, Been‐Ren, Wu, Deng‐Chyang, Tsai, Wen‐Sy, Chen, Jinn‐Shiun, Wong, Jau‐Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601572/
https://www.ncbi.nlm.nih.gov/pubmed/31063258
http://dx.doi.org/10.1002/cam4.2216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601572/
https://www.ncbi.nlm.nih.gov/pubmed/31063258
http://dx.doi.org/10.1002/cam4.2216

Ejemplares similares